Clinical Applications and Biological Targets Subcommittee: Difference between revisions
Jump to navigation
Jump to search
| Line 4: | Line 4: | ||
==Call Summaries== | ==Call Summaries== | ||
*[[Media:10.01.2012 QIBA US SWS Clinical Applications SC - FINAL.pdf |10.01.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | |||
*[[Media:09.10.2012 QIBA US SWS Clinical Applications SC - DRAFT-DC edit.pdf |09.10.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | *[[Media:09.10.2012 QIBA US SWS Clinical Applications SC - DRAFT-DC edit.pdf |09.10.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | ||
*[[Media:08.13.2012 QIBA US SWS Clinical Applications SC - DRAFT-DC edit.pdf |08.13.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | *[[Media:08.13.2012 QIBA US SWS Clinical Applications SC - DRAFT-DC edit.pdf |08.13.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | ||
*[[Media:07 23 2012 QIBA US SWS Clinical Applications SC - FINAL.pdf |07.23.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | *[[Media:07 23 2012 QIBA US SWS Clinical Applications SC - FINAL.pdf |07.23.2012 QIBA US SWS Subcommittee: Clinical Applications Call Summary]] | ||